Do biologic therapies improve symptoms, endoscopic findings, and inflammatory markers in patients with recalcitrant allergic fungal rhinosinusitis?
Randomized Trials Comparing Inferior Turbinoplasty Techniques for Nasal Obstruction
Which inferior turbinoplasty techniques provide the most durable improvement in nasal obstruction symptoms over long-term follow-up?
Dupilumab Monthly Dose De-Escalation Maintains Efficacy in CRSwNP
Does extending dupilumab dosing from every two weeks to every four weeks maintain clinical efficacy in patients with severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP)?
Long-Term Particulate Matter Exposure May Increase Risk of Chronic Rhinosinusitis with Nasal Polyposis: Results from an Exposure-Matched Study
Does long-term exposure to fine particulate matter (PM2.5) increase the risk of developing CRSwNP?
Factors Associated with High‐Risk Ergonomic Postures During Office‐ Based Rhinology Procedures: A Pilot Biomechanical Analyses
What ergonomic risks do rhinologists face during common office-based procedures, and how does procedure type influence the frequency of high-risk postures?
Comparing Efficacy of Steroid Irrigation, Steroid‐Eluting Sinus Stent, and Both Modalities on Endoscopic Outcomes After Endoscopic Sinus Surgery
What is the comparative efficacy of steroid irrigation, steroid-eluting sinus (SES) stents, and their combination in improving endoscopic outcomes following ESS in patients with chronic rhinosinusitis?
Conservative Treatment Comes First When Addressing ENS
Currently, initial treatment approaches to ENS prioritize conservative management; given the complexity and severity of the condition, patients and clinicians should approach surgical options with caution.
TXA: Potentially Useful Adjunct in the Management of Anterior Epistaxis
Current literature suggests that topical TXA could potentially be a useful adjunct in the management of anterior epistaxis.
Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection
Observation is the most cost-effective strategy for the initial management of AECRS when there is a low likelihood of bacterial infection; otherwise, upfront rescue medications are the most cost-effective.
Biologics “Switching” Common among Canadian Rhinology Patients with CRSwNP
Switching biologics for CRSwNP is frequent in Canadian rhinology; the most common switch is from mepolizumab to dupilumab, with inadequate CRSwNP control driving the switch.
- 1
- 2
- 3
- …
- 17
- Next Page »